• Mon. Sep 28th, 2020

Dimancherouge

Technology

Interference

  • Home
  • ERS Genomics Provides Comment on US Patent Office Motions Decisions in CRISPR/Cas9 Interference Case

ERS Genomics Provides Comment on US Patent Office Motions Decisions in CRISPR/Cas9 Interference Case

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier, has today provided comment on the US Patent and…